Selected research
Industry Research
Aspergillosis Drugs Industry Research Report 2026
Market perspective
The global Aspergillosis Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Aspergillosis Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Aspergillosis Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Aspergillosis Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Aspergillosis Drugs include Janssen Pharmaceutica, Tianjin Lisheng Pharmaceutical, Merck, Luoxin Biotechnology, Huasun Pharmaceutical, GSK, United Biotech, Taj Pharma and SRS Pharmaceuticals Pvt. Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Aspergillosis Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (k tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Aspergillosis Drugs Market by Company
Janssen Pharmaceutica
Tianjin Lisheng Pharmaceutical
Merck
Luoxin Biotechnology
Huasun Pharmaceutical
GSK
United Biotech
Taj Pharma
SRS Pharmaceuticals Pvt. Ltd
Pfizer Deutschland GmbH
Natco Pharma
Lepu Pharmaceuticals
Honz Pharmaceutical
Cardinal Health
Basilea Pharmaceutica
Astellas
Aspergillosis Drugs Segment by Type
Itraconazole Capsules
Caspofungin Acetate
Voriconazole Tablets
Aspergillosis Drugs Segment by Application
Invasive Aspergillosis
Allergic Bronchopulmonary Aspergillosis
Allergic Aspergillosis
Aspergillosis Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aspergillosis Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Aspergillosis Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aspergillosis Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Aspergillosis Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Aspergillosis Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Aspergillosis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Itraconazole Capsules
- Caspofungin Acetate
- Voriconazole Tablets
Applications
- Invasive Aspergillosis
- Allergic Bronchopulmonary Aspergillosis
- Allergic Aspergillosis
Companies covered
- Janssen Pharmaceutica
- Tianjin Lisheng Pharmaceutical
- Merck
- Luoxin Biotechnology
- Huasun Pharmaceutical
- GSK
- United Biotech
- Taj Pharma
- SRS Pharmaceuticals Pvt. Ltd
- Pfizer Deutschland GmbH
- Natco Pharma
- Lepu Pharmaceuticals
- Honz Pharmaceutical
- Cardinal Health
- Basilea Pharmaceutica
- Astellas
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Aspergillosis Drugs Market Size (2021-2032)
- 2.2.2 Global Aspergillosis Drugs Sales (2021-2032)
- 2.2.3 Global Aspergillosis Drugs Market Average Price (2021-2032)
- 2.3 Aspergillosis Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Itraconazole Capsules
- 2.3.3 Caspofungin Acetate
- 2.3.4 Voriconazole Tablets
- 2.4 Aspergillosis Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Invasive Aspergillosis
- 2.4.3 Allergic Bronchopulmonary Aspergillosis
- 2.4.4 Allergic Aspergillosis
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Aspergillosis Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Aspergillosis Drugs Sales (k tons) of Manufacturers (2021-2026)
- 3.3 Global Aspergillosis Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Aspergillosis Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Aspergillosis Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Aspergillosis Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Aspergillosis Drugs, Product Type & Application
- 3.8 Global Manufacturers of Aspergillosis Drugs, Established Date
- 3.9 Global Aspergillosis Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Janssen Pharmaceutica
- 4.1.1 Janssen Pharmaceutica Company Information
- 4.1.2 Janssen Pharmaceutica Business Overview
- 4.1.3 Janssen Pharmaceutica Aspergillosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Janssen Pharmaceutica Aspergillosis Drugs Product Portfolio
- 4.1.5 Janssen Pharmaceutica Recent Developments
- 4.2 Tianjin Lisheng Pharmaceutical
- 4.2.1 Tianjin Lisheng Pharmaceutical Company Information
- 4.2.2 Tianjin Lisheng Pharmaceutical Business Overview
- 4.2.3 Tianjin Lisheng Pharmaceutical Aspergillosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Tianjin Lisheng Pharmaceutical Aspergillosis Drugs Product Portfolio
- 4.2.5 Tianjin Lisheng Pharmaceutical Recent Developments
- 4.3 Merck
- 4.3.1 Merck Company Information
- 4.3.2 Merck Business Overview
- 4.3.3 Merck Aspergillosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Merck Aspergillosis Drugs Product Portfolio
- 4.3.5 Merck Recent Developments
- 4.4 Luoxin Biotechnology
- 4.4.1 Luoxin Biotechnology Company Information
- 4.4.2 Luoxin Biotechnology Business Overview
- 4.4.3 Luoxin Biotechnology Aspergillosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Luoxin Biotechnology Aspergillosis Drugs Product Portfolio
- 4.4.5 Luoxin Biotechnology Recent Developments
- 4.5 Huasun Pharmaceutical
- 4.5.1 Huasun Pharmaceutical Company Information
- 4.5.2 Huasun Pharmaceutical Business Overview
- 4.5.3 Huasun Pharmaceutical Aspergillosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Huasun Pharmaceutical Aspergillosis Drugs Product Portfolio
- 4.5.5 Huasun Pharmaceutical Recent Developments
- 4.6 GSK
- 4.6.1 GSK Company Information
- 4.6.2 GSK Business Overview
- 4.6.3 GSK Aspergillosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 GSK Aspergillosis Drugs Product Portfolio
- 4.6.5 GSK Recent Developments
- 4.7 United Biotech
- 4.7.1 United Biotech Company Information
- 4.7.2 United Biotech Business Overview
- 4.7.3 United Biotech Aspergillosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 United Biotech Aspergillosis Drugs Product Portfolio
- 4.7.5 United Biotech Recent Developments
- 4.8 Taj Pharma
- 4.8.1 Taj Pharma Company Information
- 4.8.2 Taj Pharma Business Overview
- 4.8.3 Taj Pharma Aspergillosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Taj Pharma Aspergillosis Drugs Product Portfolio
- 4.8.5 Taj Pharma Recent Developments
- 4.9 SRS Pharmaceuticals Pvt. Ltd
- 4.9.1 SRS Pharmaceuticals Pvt. Ltd Company Information
- 4.9.2 SRS Pharmaceuticals Pvt. Ltd Business Overview
- 4.9.3 SRS Pharmaceuticals Pvt. Ltd Aspergillosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 SRS Pharmaceuticals Pvt. Ltd Aspergillosis Drugs Product Portfolio
- 4.9.5 SRS Pharmaceuticals Pvt. Ltd Recent Developments
- 4.10 Pfizer Deutschland GmbH
- 4.10.1 Pfizer Deutschland GmbH Company Information
- 4.10.2 Pfizer Deutschland GmbH Business Overview
- 4.10.3 Pfizer Deutschland GmbH Aspergillosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Pfizer Deutschland GmbH Aspergillosis Drugs Product Portfolio
- 4.10.5 Pfizer Deutschland GmbH Recent Developments
- 4.11 Natco Pharma
- 4.11.1 Natco Pharma Company Information
- 4.11.2 Natco Pharma Business Overview
- 4.11.3 Natco Pharma Aspergillosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Natco Pharma Aspergillosis Drugs Product Portfolio
- 4.11.5 Natco Pharma Recent Developments
- 4.12 Lepu Pharmaceuticals
- 4.12.1 Lepu Pharmaceuticals Company Information
- 4.12.2 Lepu Pharmaceuticals Business Overview
- 4.12.3 Lepu Pharmaceuticals Aspergillosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Lepu Pharmaceuticals Aspergillosis Drugs Product Portfolio
- 4.12.5 Lepu Pharmaceuticals Recent Developments
- 4.13 Honz Pharmaceutical
- 4.13.1 Honz Pharmaceutical Company Information
- 4.13.2 Honz Pharmaceutical Business Overview
- 4.13.3 Honz Pharmaceutical Aspergillosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Honz Pharmaceutical Aspergillosis Drugs Product Portfolio
- 4.13.5 Honz Pharmaceutical Recent Developments
- 4.14 Cardinal Health
- 4.14.1 Cardinal Health Company Information
- 4.14.2 Cardinal Health Business Overview
- 4.14.3 Cardinal Health Aspergillosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Cardinal Health Aspergillosis Drugs Product Portfolio
- 4.14.5 Cardinal Health Recent Developments
- 4.15 Basilea Pharmaceutica
- 4.15.1 Basilea Pharmaceutica Company Information
- 4.15.2 Basilea Pharmaceutica Business Overview
- 4.15.3 Basilea Pharmaceutica Aspergillosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Basilea Pharmaceutica Aspergillosis Drugs Product Portfolio
- 4.15.5 Basilea Pharmaceutica Recent Developments
- 4.16 Astellas
- 4.16.1 Astellas Company Information
- 4.16.2 Astellas Business Overview
- 4.16.3 Astellas Aspergillosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Astellas Aspergillosis Drugs Product Portfolio
- 4.16.5 Astellas Recent Developments
5 Global Aspergillosis Drugs Market Scenario by Region
- 5.1 Global Aspergillosis Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Aspergillosis Drugs Sales by Region: 2021-2032
- 5.2.1 Global Aspergillosis Drugs Sales by Region: 2021-2026
- 5.2.2 Global Aspergillosis Drugs Sales by Region: 2027-2032
- 5.3 Global Aspergillosis Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Aspergillosis Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Aspergillosis Drugs Revenue by Region: 2027-2032
- 5.4 North America Aspergillosis Drugs Market Facts & Figures by Country
- 5.4.1 North America Aspergillosis Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Aspergillosis Drugs Sales by Country (2021-2032)
- 5.4.3 North America Aspergillosis Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Aspergillosis Drugs Market Facts & Figures by Country
- 5.5.1 Europe Aspergillosis Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Aspergillosis Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Aspergillosis Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Aspergillosis Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Aspergillosis Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Aspergillosis Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Aspergillosis Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Aspergillosis Drugs Market Facts & Figures by Country
- 5.7.1 South America Aspergillosis Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Aspergillosis Drugs Sales by Country (2021-2032)
- 5.7.3 South America Aspergillosis Drugs Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Aspergillosis Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Aspergillosis Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Aspergillosis Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Aspergillosis Drugs Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Aspergillosis Drugs Sales by Type (2021-2032)
- 6.1.1 Global Aspergillosis Drugs Sales by Type (2021-2032) & (k tons)
- 6.1.2 Global Aspergillosis Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Aspergillosis Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Aspergillosis Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Aspergillosis Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Aspergillosis Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Aspergillosis Drugs Sales by Application (2021-2032)
- 7.1.1 Global Aspergillosis Drugs Sales by Application (2021-2032) & (k tons)
- 7.1.2 Global Aspergillosis Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Aspergillosis Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Aspergillosis Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Aspergillosis Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Aspergillosis Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Aspergillosis Drugs Value Chain Analysis
- 8.1.1 Aspergillosis Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Aspergillosis Drugs Production Mode & Process
- 8.2 Aspergillosis Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Aspergillosis Drugs Distributors
- 8.2.3 Aspergillosis Drugs Customers
9 Global Aspergillosis Drugs Analyzing Market Dynamics
- 9.1 Aspergillosis Drugs Industry Trends
- 9.2 Aspergillosis Drugs Industry Drivers
- 9.3 Aspergillosis Drugs Industry Opportunities and Challenges
- 9.4 Aspergillosis Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst